-
1
-
-
84876101644
-
Depression fact sheet (No. 369)
-
(accessed June 28, 2016).
-
WHO. Depression fact sheet (No. 369). http://www.who.int/mediacentre/factsheets/fs369/en/, 2016 (accessed June 28, 2016).
-
(2016)
-
-
-
2
-
-
84876830344
-
Depression: a global public health concern
-
(accessed June 28, 2016).
-
WHO. Depression: a global public health concern. http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf, 2012 (accessed June 28, 2016).
-
(2012)
-
-
-
3
-
-
84857039429
-
Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review
-
Undurraga, J, Baldessarini, RJ, Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 37 (2011), 851–862.
-
(2011)
Neuropsychopharmacology
, vol.37
, pp. 851-862
-
-
Undurraga, J.1
Baldessarini, R.J.2
-
4
-
-
84955262240
-
Is treatment-resistant depression a useful concept?
-
Malhi, GS, Byrow, Y, Is treatment-resistant depression a useful concept?. Evidence Based Mental Health 19 (2016), 1–3.
-
(2016)
Evidence Based Mental Health
, vol.19
, pp. 1-3
-
-
Malhi, G.S.1
Byrow, Y.2
-
5
-
-
0023149820
-
Use of pattern analysis to identify true drug response. A replication
-
Quitkin, F, Rabkin, J, Markowitz, J, Stewart, JW, McGrath, P, Harrison, W, Use of pattern analysis to identify true drug response. A replication. Arch Gen Psychiatry 44 (1987), 259–264.
-
(1987)
Arch Gen Psychiatry
, vol.44
, pp. 259-264
-
-
Quitkin, F.1
Rabkin, J.2
Markowitz, J.3
Stewart, J.W.4
McGrath, P.5
Harrison, W.6
-
6
-
-
0021277596
-
Identification of true drug response to anti-depressants. Use of pattern analysis
-
Quitkin, F, Rabkin, J, Ross, D, Stewart, JW, Identification of true drug response to anti-depressants. Use of pattern analysis. Arch Gen Psychiatry 41 (1984), 782–786.
-
(1984)
Arch Gen Psychiatry
, vol.41
, pp. 782-786
-
-
Quitkin, F.1
Rabkin, J.2
Ross, D.3
Stewart, J.W.4
-
7
-
-
84892146092
-
Quality of reporting in systematic reviews of adverse events: systematic review
-
Zorzela, L, Golder, A, Liu, Y, Pilklington, K, Hartling, L, Joffe, A, Quality of reporting in systematic reviews of adverse events: systematic review. BMJ, 348, 2014, 7668.
-
(2014)
BMJ
, vol.348
, pp. 7668
-
-
Zorzela, L.1
Golder, A.2
Liu, Y.3
Pilklington, K.4
Hartling, L.5
Joffe, A.6
-
8
-
-
0033969685
-
Antidepressant effects of ketamine in depressed patients
-
Berman, RM, Cappiello, A, Anand, A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47 (2000), 351–354.
-
(2000)
Biol Psychiatry
, vol.47
, pp. 351-354
-
-
Berman, R.M.1
Cappiello, A.2
Anand, A.3
-
9
-
-
84966349654
-
Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis
-
Xu, Y, Hackett, M, Carter, G, et al. Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis. Int J Neuropsychopharmacol, 19, 2016, pyv124.
-
(2016)
Int J Neuropsychopharmacol
, vol.19
, pp. pyv124
-
-
Xu, Y.1
Hackett, M.2
Carter, G.3
-
10
-
-
71649098114
-
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression
-
aan het Rot, M, Collins, KA, Murrough, JW, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67 (2010), 139–145.
-
(2010)
Biol Psychiatry
, vol.67
, pp. 139-145
-
-
aan het Rot, M.1
Collins, K.A.2
Murrough, J.W.3
-
11
-
-
84880852239
-
Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial
-
Irwin, SA, Iglewicz, A, Nelesen, RA, et al. Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial. J Palliat Med 16 (2013), 958–965.
-
(2013)
J Palliat Med
, vol.16
, pp. 958-965
-
-
Irwin, S.A.1
Iglewicz, A.2
Nelesen, R.A.3
-
12
-
-
84880767967
-
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression
-
Murrough, JW, Perez, AM, Pillemer, S, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74 (2013), 250–256.
-
(2013)
Biol Psychiatry
, vol.74
, pp. 250-256
-
-
Murrough, J.W.1
Perez, A.M.2
Pillemer, S.3
-
13
-
-
84876531468
-
Serial infusions of low-dose ketamine for major depression
-
Rasmussen, KG, Lineberry, TW, Galardy, CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol 27 (2013), 444–450.
-
(2013)
J Psychopharmacol
, vol.27
, pp. 444-450
-
-
Rasmussen, K.G.1
Lineberry, T.W.2
Galardy, C.W.3
-
14
-
-
84898003445
-
Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic
-
Diamond, PR, Farmery, AD, Atkinson, S, et al. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic. J Psychopharmacol 28 (2014), 536–544.
-
(2014)
J Psychopharmacol
, vol.28
, pp. 536-544
-
-
Diamond, P.R.1
Farmery, A.D.2
Atkinson, S.3
-
15
-
-
84891852276
-
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
-
Shiroma, PR, Johns, B, Kuskowski, M, et al. Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression. J Affect Disord 155 (2014), 123–129.
-
(2014)
J Affect Disord
, vol.155
, pp. 123-129
-
-
Shiroma, P.R.1
Johns, B.2
Kuskowski, M.3
-
16
-
-
84938935980
-
Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT
-
Allen, AP, Naughton, M, Dowling, J, et al. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT. J Affect Disord 186 (2015), 306–311.
-
(2015)
J Affect Disord
, vol.186
, pp. 306-311
-
-
Allen, A.P.1
Naughton, M.2
Dowling, J.3
-
17
-
-
85008682134
-
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
-
Cusin, C, Ionescu, DF, Pavone, KJ, et al. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation. Aust N Z J Psychiatry 51 (2016), 55–64.
-
(2016)
Aust N Z J Psychiatry
, vol.51
, pp. 55-64
-
-
Cusin, C.1
Ionescu, D.F.2
Pavone, K.J.3
-
18
-
-
33644772133
-
Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions
-
Correll, GE, Futter, GE, Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions. Pain Med 7 (2006), 92–95.
-
(2006)
Pain Med
, vol.7
, pp. 92-95
-
-
Correll, G.E.1
Futter, G.E.2
-
19
-
-
56749177533
-
Intravenous ketamine “burst” for refractory depression in a patient with advanced cancer
-
Stefanczyk-Sapieha, L, Oneschuk, D, Demas, M, Intravenous ketamine “burst” for refractory depression in a patient with advanced cancer. J Palliat Med 11 (2008), 1268–1271.
-
(2008)
J Palliat Med
, vol.11
, pp. 1268-1271
-
-
Stefanczyk-Sapieha, L.1
Oneschuk, D.2
Demas, M.3
-
20
-
-
68549092716
-
Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases
-
Paul, R, Schaaff, N, Padberg, F, Moller, HJ, Frodl, T, Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases. World J Biol Psychiatry 10 (2009), 241–244.
-
(2009)
World J Biol Psychiatry
, vol.10
, pp. 241-244
-
-
Paul, R.1
Schaaff, N.2
Padberg, F.3
Moller, H.J.4
Frodl, T.5
-
21
-
-
76349084738
-
Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series
-
Paslakis, G, Gilles, M, Meyer-Lindenberg, A, Deuschle, M, Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series. Pharmacopsychiatry 43 (2010), 33–35.
-
(2010)
Pharmacopsychiatry
, vol.43
, pp. 33-35
-
-
Paslakis, G.1
Gilles, M.2
Meyer-Lindenberg, A.3
Deuschle, M.4
-
22
-
-
79953057998
-
A case of sustained remission following an acute course of ketamine in treatment-resistant depression
-
Murrough, JW, Perez, AM, Mathew, SJ, Charney, DS, A case of sustained remission following an acute course of ketamine in treatment-resistant depression. J Clin Psychiatry 72 (2011), 414–415.
-
(2011)
J Clin Psychiatry
, vol.72
, pp. 414-415
-
-
Murrough, J.W.1
Perez, A.M.2
Mathew, S.J.3
Charney, D.S.4
-
23
-
-
84864288609
-
On the safety and benefits of repeated intravenous injections of ketamine for depression
-
Blier, P, Zigman, D, Blier, J, On the safety and benefits of repeated intravenous injections of ketamine for depression. Biol Psychiatry 72 (2012), e11–e12.
-
(2012)
Biol Psychiatry
, vol.72
, pp. e11-e12
-
-
Blier, P.1
Zigman, D.2
Blier, J.3
-
24
-
-
84864807084
-
Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression
-
Cusin, C, Hilton, GQ, Nierengerg, AA, Fava, M, Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression. Am J Psychiatry 169 (2012), 868–869.
-
(2012)
Am J Psychiatry
, vol.169
, pp. 868-869
-
-
Cusin, C.1
Hilton, G.Q.2
Nierengerg, A.A.3
Fava, M.4
-
25
-
-
84883324216
-
Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
-
Lara, DR, Bisol, LW, Munari, LR, Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression. Int J Neuropsychopharmacol 16 (2013), 2111–2117.
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, pp. 2111-2117
-
-
Lara, D.R.1
Bisol, L.W.2
Munari, L.R.3
-
26
-
-
85040148133
-
Maintenance ketamine treatment produces long-term recovery from depression
-
(accessed Jan 11, 2017).
-
Messer, M, Haller, I, Maintenance ketamine treatment produces long-term recovery from depression. http://primarypsychiatry.com/maintenance-ketamine-treatment-produces-long-term-recovery-from-depression/, May 21, 2013 (accessed Jan 11, 2017).
-
(2013)
-
-
Messer, M.1
Haller, I.2
-
27
-
-
84888002513
-
Ketamine for treatment of therapy-resistant depression: a case study
-
(in German).
-
Segmiller, F, Frisse, D, Eser, D, Moller, HJ, Ruther, T, Schule, C, Ketamine for treatment of therapy-resistant depression: a case study. Nervenarzt 84 (2013), 854–855 (in German).
-
(2013)
Nervenarzt
, vol.84
, pp. 854-855
-
-
Segmiller, F.1
Frisse, D.2
Eser, D.3
Moller, H.J.4
Ruther, T.5
Schule, C.6
-
28
-
-
84885066566
-
Repeated S-ketamine infusions in therapy resistant depression: a case series
-
Segmiller, F, Ruther, T, Linhardt, A, et al. Repeated S-ketamine infusions in therapy resistant depression: a case series. J Clin Pharmacol 53 (2013), 996–998.
-
(2013)
J Clin Pharmacol
, vol.53
, pp. 996-998
-
-
Segmiller, F.1
Ruther, T.2
Linhardt, A.3
-
29
-
-
84875366335
-
A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression
-
Szymkowicz, SM, Finnegan, N, Dale, RM, A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression. J Affect Disord 147 (2013), 416–420.
-
(2013)
J Affect Disord
, vol.147
, pp. 416-420
-
-
Szymkowicz, S.M.1
Finnegan, N.2
Dale, R.M.3
-
30
-
-
84880467266
-
Case report: Long-term mood response to repeat dose intramuscular ketamine in a depressed patient with advanced cancer
-
Zanicotti, CG, Perez, D, Glue, P, Case report: Long-term mood response to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. J Palliat Med 16 (2013), 719–720.
-
(2013)
J Palliat Med
, vol.16
, pp. 719-720
-
-
Zanicotti, C.G.1
Perez, D.2
Glue, P.3
-
31
-
-
84904043755
-
Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report
-
Galvez, V, O'Keefe, E, Cotiga, L, et al. Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report. Biol Psychiatry 76 (2014), e1–e2.
-
(2014)
Biol Psychiatry
, vol.76
, pp. e1-e2
-
-
Galvez, V.1
O'Keefe, E.2
Cotiga, L.3
-
32
-
-
84894251759
-
Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy
-
(in Polish).
-
Gosek, P, Chojnacka, M, Bienkowski, P, Swiecicki, L, Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy. Psychiatr Pol 48 (2014), 49–58 (in Polish).
-
(2014)
Psychiatr Pol
, vol.48
, pp. 49-58
-
-
Gosek, P.1
Chojnacka, M.2
Bienkowski, P.3
Swiecicki, L.4
-
33
-
-
84941884143
-
Augmentation therapy with serial intravenous ketamine over 18 months in a patient with treatment resistant depression
-
Hassamal, S, Spivey, M, Pandurangi, AK, Augmentation therapy with serial intravenous ketamine over 18 months in a patient with treatment resistant depression. Clin Neuropharmacol 38 (2015), 212–216.
-
(2015)
Clin Neuropharmacol
, vol.38
, pp. 212-216
-
-
Hassamal, S.1
Spivey, M.2
Pandurangi, A.K.3
-
34
-
-
85040151322
-
Ketamine (INN). Update review report. Agenda Item 6.1. Expert Committee on Drug Dependence, Thirty-seventh Meeting 2015
-
(accessed July 26, 2016).
-
WHO. Ketamine (INN). Update review report. Agenda Item 6.1. Expert Committee on Drug Dependence, Thirty-seventh Meeting 2015. http://www.who.int/medicines/access/controlledsubstances/6_1_Ketamine_Update_Review.pdf (accessed July 26, 2016).
-
-
-
-
35
-
-
84884218593
-
Ketamine as a new treatment for depression: a review of its efficacy and adverse effects
-
Katalinic, N, Lai, R, Somogyi, A, Mitchell, PB, Glue, P, Loo, CK, Ketamine as a new treatment for depression: a review of its efficacy and adverse effects. Aust N Z J Psychiatry 47 (2013), 710–727.
-
(2013)
Aust N Z J Psychiatry
, vol.47
, pp. 710-727
-
-
Katalinic, N.1
Lai, R.2
Somogyi, A.3
Mitchell, P.B.4
Glue, P.5
Loo, C.K.6
-
36
-
-
83355169638
-
Ketamine use: a review
-
Morgan, CJ, Curran, HV, Independent Scientific Committee on D. Ketamine use: a review. Addiction 107 (2012), 27–38.
-
(2012)
Addiction
, vol.107
, pp. 27-38
-
-
Morgan, C.J.1
Curran, H.V.2
-
37
-
-
85040147305
-
Ketamine offered to patients with depression in take-home, DIY packs by controversial clinic
-
(accessed Jan 10, 2017).
-
Worthington, E, Ketamine offered to patients with depression in take-home, DIY packs by controversial clinic. ABC News, May 30, 2015 http://www.abc.net.au/news/2015-05-30/ketamine-offered-to-patients-with-depression-in-take-home-packs/6508232 (accessed Jan 10, 2017).
-
(2015)
ABC News
-
-
Worthington, E.1
-
38
-
-
85040146704
-
Medical clinics promote ketamine injections as treatment for depression
-
(accessed Jan 10, 2017).
-
Kembrey, M, Medical clinics promote ketamine injections as treatment for depression. Sydney Morning Herald, Feb 18, 2015 http://www.smh.com.au/nsw/medical-clinics-promote-ketamine-injections-as-treatment-for-depression-20150217-13h51o.html (accessed Jan 10, 2017).
-
(2015)
Sydney Morning Herald
-
-
Kembrey, M.1
-
39
-
-
85040151209
-
Could ketamine become the next great depression drug?
-
(accessed Jan 12, 2017).
-
Bella, T, Could ketamine become the next great depression drug?. Aljazeera America, Feb 12, 2015 http://america.aljazeera.com/watch/shows/america-tonight/articles/2015/2/12/Ketamine.html (accessed Jan 12, 2017).
-
(2015)
Aljazeera America
-
-
Bella, T.1
-
40
-
-
84954134987
-
Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
-
Zhang, MW, Harris, KM, Ho, RC, Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications. BMC Medical Ethics, 17, 2016, 4.
-
(2016)
BMC Medical Ethics
, vol.17
, pp. 4
-
-
Zhang, M.W.1
Harris, K.M.2
Ho, R.C.3
-
41
-
-
79956219650
-
Adverse effects
-
JP Higgins S Green John Wiley & Sons Chichester
-
Loke, YK, Price, D, Herxheimer, A, Adverse effects. Higgins, JP, Green, S, (eds.) Cochrane handbook for systematic reviews of interventions, 2009, John Wiley & Sons, Chichester.
-
(2009)
Cochrane handbook for systematic reviews of interventions
-
-
Loke, Y.K.1
Price, D.2
Herxheimer, A.3
-
42
-
-
34547626058
-
Systematic reviews of adverse effects: framework for a structured approach
-
Loke, YK, Price, D, Herxheimer, A, Cochrane Adverse Effects Methods Group. Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol, 7, 2007, 32.
-
(2007)
BMC Med Res Methodol
, vol.7
, pp. 32
-
-
Loke, Y.K.1
Price, D.2
Herxheimer, A.3
-
43
-
-
0036289697
-
Small-dose ketamine improves the postoperative state of depressed patients
-
Kudoh, A, Takahira, Y, Katagai, H, Takazawa, T, Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95 (2002), 114–118.
-
(2002)
Anesth Analg
, vol.95
, pp. 114-118
-
-
Kudoh, A.1
Takahira, Y.2
Katagai, H.3
Takazawa, T.4
-
44
-
-
33746896935
-
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
-
Zarate, CA Jr, Singh, JB, Carlson, PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63 (2006), 856–864.
-
(2006)
Arch Gen Psychiatry
, vol.63
, pp. 856-864
-
-
Zarate, C.A.1
Singh, J.B.2
Carlson, P.J.3
-
45
-
-
77955891255
-
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
-
Diazgranados, N, Ibrahim, L, Brutsche, NE, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67 (2010), 793–802.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 793-802
-
-
Diazgranados, N.1
Ibrahim, L.2
Brutsche, N.E.3
-
46
-
-
84861099072
-
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial
-
Zarate, CA Jr, Brutsche, NE, Ibrahim, L, et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71 (2012), 939–946.
-
(2012)
Biol Psychiatry
, vol.71
, pp. 939-946
-
-
Zarate, C.A.1
Brutsche, N.E.2
Ibrahim, L.3
-
47
-
-
84885214350
-
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial
-
Murrough, JW, Iosifescu, DV, Chang, LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 170 (2013), 1134–1142.
-
(2013)
Am J Psychiatry
, vol.170
, pp. 1134-1142
-
-
Murrough, J.W.1
Iosifescu, D.V.2
Chang, L.C.3
-
48
-
-
84925457771
-
Efficacy and safety of intravenous esketamine in patients with treatment-resistant depression: a double-blind, double-randomization, placebo controlled phase 2a study
-
Singh, J, Fedgchin, M, Daly, E, et al. Efficacy and safety of intravenous esketamine in patients with treatment-resistant depression: a double-blind, double-randomization, placebo controlled phase 2a study. Neuropsychopharmacology 38 (2013), s369–s370.
-
(2013)
Neuropsychopharmacology
, vol.38
, pp. s369-s370
-
-
Singh, J.1
Fedgchin, M.2
Daly, E.3
-
49
-
-
84880555463
-
Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression
-
Sos, P, Klirova, M, Novak, T, Kohutova, B, Horacek, J, Palenicek, T, Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression. Neuro Endocrinol Lett 34 (2013), 287–293.
-
(2013)
Neuro Endocrinol Lett
, vol.34
, pp. 287-293
-
-
Sos, P.1
Klirova, M.2
Novak, T.3
Kohutova, B.4
Horacek, J.5
Palenicek, T.6
-
50
-
-
84893715460
-
Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder
-
Ghasemi, M, Kazemi, MH, Yoosefi, A, et al. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res 215 (2014), 355–361.
-
(2014)
Psychiatry Res
, vol.215
, pp. 355-361
-
-
Ghasemi, M.1
Kazemi, M.H.2
Yoosefi, A.3
-
51
-
-
84907260750
-
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression
-
Lai, R, Katalinic, N, Glue, P, et al. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry 15 (2014), 579–584.
-
(2014)
World J Biol Psychiatry
, vol.15
, pp. 579-584
-
-
Lai, R.1
Katalinic, N.2
Glue, P.3
-
52
-
-
84919398586
-
A randomized controlled trial of intranasal ketamine in major depressive disorder
-
Lapidus, KA, Levitch, CF, Perez, AM, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 76 (2014), 970–976.
-
(2014)
Biol Psychiatry
, vol.76
, pp. 970-976
-
-
Lapidus, K.A.1
Levitch, C.F.2
Perez, A.M.3
-
53
-
-
84945478974
-
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
-
Murrough, J, Soleimani, L, DeWilde, K, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med 45 (2015), 3571–3580.
-
(2015)
Psychol Med
, vol.45
, pp. 3571-3580
-
-
Murrough, J.1
Soleimani, L.2
DeWilde, K.3
-
54
-
-
84961160408
-
Single I.V. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
-
Hu, Y, Xiang, Y, Fang, J, et al. Single I.V. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study. Psychol Med 46 (2015), 623–635.
-
(2015)
Psychol Med
, vol.46
, pp. 623-635
-
-
Hu, Y.1
Xiang, Y.2
Fang, J.3
-
55
-
-
84959190094
-
Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: a pilot randomised controlled trial
-
Lenze, EJ, Farber, NB, Kharasch, E, et al. Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: a pilot randomised controlled trial. World J Biol Psychiatry 17 (2016), 230–238.
-
(2016)
World J Biol Psychiatry
, vol.17
, pp. 230-238
-
-
Lenze, E.J.1
Farber, N.B.2
Kharasch, E.3
-
56
-
-
84958236573
-
The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: a randomized controlled study
-
Li, C-T, Chen, M-H, Lin, W-C, et al. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: a randomized controlled study. Hum Brain Mapp 37 (2016), 1080–1090.
-
(2016)
Hum Brain Mapp
, vol.37
, pp. 1080-1090
-
-
Li, C.-T.1
Chen, M.-H.2
Lin, W.-C.3
-
57
-
-
84973610912
-
Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
-
Loo, C, Galvez, V, O'Keefe, E, et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr Scand 134 (2016), 48–56.
-
(2016)
Acta Psychiatr Scand
, vol.134
, pp. 48-56
-
-
Loo, C.1
Galvez, V.2
O'Keefe, E.3
-
58
-
-
84991272304
-
A double-blind, randomized, placebo-controlled, parallel group, dose frequency study of intravenous ketamine in patients with treatment-resistant depression
-
Singh, J, Fedgchin, M, Daly, E, et al. A double-blind, randomized, placebo-controlled, parallel group, dose frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry 173 (2016), 816–826.
-
(2016)
Am J Psychiatry
, vol.173
, pp. 816-826
-
-
Singh, J.1
Fedgchin, M.2
Daly, E.3
-
59
-
-
84975144373
-
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial
-
Jafarinia, M, Afarideh, M, Tafakhori, A, et al. Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial. J Affect Disord 204 (2016), 1–8.
-
(2016)
J Affect Disord
, vol.204
, pp. 1-8
-
-
Jafarinia, M.1
Afarideh, M.2
Tafakhori, A.3
-
60
-
-
84964577685
-
Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
-
Downey, D, Dutta, A, McKie, S, et al. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate. Eur Neuropsychopharmacol 26 (2016), 994–1003.
-
(2016)
Eur Neuropsychopharmacol
, vol.26
, pp. 994-1003
-
-
Downey, D.1
Dutta, A.2
McKie, S.3
-
61
-
-
85040139996
-
-
Pilot randomized-controlled trial of titrated subcutaneous ketamine in older patients with treatment resistant depression. Am J Geriatric Psychiatry (in press).
-
George D, Galvez V, Martin D, et al. Pilot randomized-controlled trial of titrated subcutaneous ketamine in older patients with treatment resistant depression. Am J Geriatric Psychiatry (in press).
-
-
-
George, D.1
Galvez, V.2
Martin, D.3
-
62
-
-
58049211903
-
Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist
-
Phelps, LE, Brustch, N, Moral, JR, Luckenbaugh, D, Manji, H, Zarate, C, Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry 65 (2009), 181–184.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 181-184
-
-
Phelps, L.E.1
Brustch, N.2
Moral, J.R.3
Luckenbaugh, D.4
Manji, H.5
Zarate, C.6
-
63
-
-
77949625234
-
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
-
Mathew, SJ, Murrough, JW, aan het Rot, M, Collins, KA, Reich, DL, Charney, DS, Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol 13 (2010), 71–82.
-
(2010)
Int J Neuropsychopharmacol
, vol.13
, pp. 71-82
-
-
Mathew, S.J.1
Murrough, J.W.2
aan het Rot, M.3
Collins, K.A.4
Reich, D.L.5
Charney, D.S.6
-
64
-
-
79955993457
-
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
-
Ibrahim, L, Diazgranados, N, Luckenbaugh, DA, et al. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 35 (2011), 1155–1159.
-
(2011)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.35
, pp. 1155-1159
-
-
Ibrahim, L.1
Diazgranados, N.2
Luckenbaugh, D.A.3
-
65
-
-
80053025475
-
A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
-
Larkin, GL, Beautrais, AL, A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 14 (2011), 1127–1131.
-
(2011)
Int J Neuropsychopharmacol
, vol.14
, pp. 1127-1131
-
-
Larkin, G.L.1
Beautrais, A.L.2
-
66
-
-
78751701060
-
The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS
-
Valentine, GW, Mason, GF, Gomez, R, et al. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res 191 (2011), 122–127.
-
(2011)
Psychiatry Res
, vol.191
, pp. 122-127
-
-
Valentine, G.W.1
Mason, G.F.2
Gomez, R.3
-
67
-
-
84859777474
-
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study
-
Ibrahim, L, Diazgranados, N, Franco-Chaves, J, et al. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology 37 (2012), 1526–1533.
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 1526-1533
-
-
Ibrahim, L.1
Diazgranados, N.2
Franco-Chaves, J.3
-
68
-
-
84864286398
-
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression
-
Zarate, CA Jr, Brutsche, N, Laje, G, et al. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry 72 (2012), 331–338.
-
(2012)
Biol Psychiatry
, vol.72
, pp. 331-338
-
-
Zarate, C.A.1
Brutsche, N.2
Laje, G.3
-
69
-
-
84930416474
-
A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
-
Ionescu, DF, Luckenbaugh, DA, Niciu, MJ, Richards, EM, Zarate, CA Jr, A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disord 17 (2015), 438–443.
-
(2015)
Bipolar Disord
, vol.17
, pp. 438-443
-
-
Ionescu, D.F.1
Luckenbaugh, D.A.2
Niciu, M.J.3
Richards, E.M.4
Zarate, C.A.5
-
70
-
-
84932626621
-
Single-dose ketamine followed by daily D-cycloserine in treatment-resistant bipolar depression
-
Kantrowitz, JT, Halberstam, B, Gangwisch, J, Single-dose ketamine followed by daily D-cycloserine in treatment-resistant bipolar depression. J Clin Psychiatry 76 (2015), 737–738.
-
(2015)
J Clin Psychiatry
, vol.76
, pp. 737-738
-
-
Kantrowitz, J.T.1
Halberstam, B.2
Gangwisch, J.3
-
71
-
-
77954950428
-
Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care
-
Irwin, SA, Iglewicz, A, Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care. J Palliat Med 13 (2010), 903–908.
-
(2010)
J Palliat Med
, vol.13
, pp. 903-908
-
-
Irwin, S.A.1
Iglewicz, A.2
-
72
-
-
84879407498
-
Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder
-
Niciu, MJ, Grunschel, BD, Corlett, PR, Pittenger, C, Bloch, MH, Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder. J Psychopharmacol 27 (2013), 651–654.
-
(2013)
J Psychopharmacol
, vol.27
, pp. 651-654
-
-
Niciu, M.J.1
Grunschel, B.D.2
Corlett, P.R.3
Pittenger, C.4
Bloch, M.H.5
-
73
-
-
84876440651
-
Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder
-
Womble, AL, Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder. AANA J 81 (2013), 118–119.
-
(2013)
AANA J
, vol.81
, pp. 118-119
-
-
Womble, A.L.1
-
74
-
-
84903707853
-
Rapid resolution of suicidal behavior and depression with single low-dose ketamine intravenous push even after 6 months of follow-up
-
Aligeti, S, Quinones, M, Salazar, R, Rapid resolution of suicidal behavior and depression with single low-dose ketamine intravenous push even after 6 months of follow-up. J Clin Psychopharmacol 34 (2014), 533–535.
-
(2014)
J Clin Psychopharmacol
, vol.34
, pp. 533-535
-
-
Aligeti, S.1
Quinones, M.2
Salazar, R.3
-
75
-
-
85065112137
-
Experience integrating ketamine into the healthcare system: outpatient and inpatient treatment of post-partum depression, suicidal ideation and comorbid chronic pain-mood disorders
-
Quinones, M, Diazgranados, N, Eckmann, M, Ramamurthy, S, Bowden, C, Delgado, PL, Experience integrating ketamine into the healthcare system: outpatient and inpatient treatment of post-partum depression, suicidal ideation and comorbid chronic pain-mood disorders. Neuropsychopharmacology 38 (2012), s442–s443.
-
(2012)
Neuropsychopharmacology
, vol.38
, pp. s442-s443
-
-
Quinones, M.1
Diazgranados, N.2
Eckmann, M.3
Ramamurthy, S.4
Bowden, C.5
Delgado, P.L.6
-
76
-
-
84937520979
-
Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases
-
Iglewicz, A, Morrison, K, Nelesen, RA, et al. Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases. Psychosomatics 56 (2015), 329–337.
-
(2015)
Psychosomatics
, vol.56
, pp. 329-337
-
-
Iglewicz, A.1
Morrison, K.2
Nelesen, R.A.3
-
77
-
-
84945176342
-
Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review
-
Nguyen, L, Marshalek, PJ, Weaver, CB, Cramer, KJ, Pollard, SE, Matsumoto, RR, Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review. Neuropsychiatric Dis Treat 11 (2015), 2667–2673.
-
(2015)
Neuropsychiatric Dis Treat
, vol.11
, pp. 2667-2673
-
-
Nguyen, L.1
Marshalek, P.J.2
Weaver, C.B.3
Cramer, K.J.4
Pollard, S.E.5
Matsumoto, R.R.6
-
78
-
-
84925487684
-
Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial
-
Murrough, JW, Burdick, KE, Levitch, CF, et al. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial. Neuropsychopharmacology 40 (2015), 1084–1090.
-
(2015)
Neuropsychopharmacology
, vol.40
, pp. 1084-1090
-
-
Murrough, J.W.1
Burdick, K.E.2
Levitch, C.F.3
-
79
-
-
84892805424
-
Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
-
Murrough, JW, Wan, L-B, Iacoviello, B, et al. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology 231 (2014), 481–488.
-
(2014)
Psychopharmacology
, vol.231
, pp. 481-488
-
-
Murrough, J.W.1
Wan, L.-B.2
Iacoviello, B.3
-
80
-
-
84922041650
-
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine
-
Ionescu, DF, Luckenbaugh, DA, Niciu, MJ, et al. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine. J Clin Psychiatry 75 (2014), e932–e938.
-
(2014)
J Clin Psychiatry
, vol.75
, pp. e932-e938
-
-
Ionescu, D.F.1
Luckenbaugh, D.A.2
Niciu, M.J.3
-
81
-
-
84915745090
-
Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
-
Sahu, R, Yadav, R, Prasad, P, Roy, A, Chandrakar, S, Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. SpringerPlus, 3, 2014, 695.
-
(2014)
SpringerPlus
, vol.3
, pp. 695
-
-
Sahu, R.1
Yadav, R.2
Prasad, P.3
Roy, A.4
Chandrakar, S.5
-
82
-
-
45849119038
-
Pharmacovigilance: methods, recent developments and future perspective
-
Harmark, L, Van Grootheest, A, Pharmacovigilance: methods, recent developments and future perspective. Eur J Clin Pharmacol 64 (2008), 743–752.
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 743-752
-
-
Harmark, L.1
Van Grootheest, A.2
-
83
-
-
85040145707
-
Fact file on ketamine 2016
-
(accessed July 9, 2016).
-
WHO. Fact file on ketamine 2016. http://www.who.int/medicines/news/20160309_FactFile_Ketamine.pdf, July 9, 2016 (accessed July 9, 2016).
-
(2016)
-
-
-
84
-
-
34247580765
-
Ketamine-associated ulcerative cystitis: a new clinical entity
-
Shahani, R, Streutker, C, Dickson, B, Stewart, RJ, Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69 (2007), 810–812.
-
(2007)
Urology
, vol.69
, pp. 810-812
-
-
Shahani, R.1
Streutker, C.2
Dickson, B.3
Stewart, R.J.4
-
85
-
-
80052744525
-
The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use
-
Kalsi, SS, Wood, DM, Dargan, PI, The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J, 4, 2011, 7107.
-
(2011)
Emerg Health Threats J
, vol.4
, pp. 7107
-
-
Kalsi, S.S.1
Wood, D.M.2
Dargan, P.I.3
-
86
-
-
77957654863
-
Ketamine-associated ulcerative cystitis: a case report and literature review
-
Ho, CC, Pezhman, H, Praveen, S, Goh, E, Lee, B, Zulkifli, M, Ketamine-associated ulcerative cystitis: a case report and literature review. Malays J Med Sci 17 (2009), 61–65.
-
(2009)
Malays J Med Sci
, vol.17
, pp. 61-65
-
-
Ho, C.C.1
Pezhman, H.2
Praveen, S.3
Goh, E.4
Lee, B.5
Zulkifli, M.6
-
87
-
-
78650437364
-
Ketamine induced vesicopathy: a literature review
-
Middela, S, Pearce, I, Ketamine induced vesicopathy: a literature review. Int J Clin Pract, 65, 2010, 27.
-
(2010)
Int J Clin Pract
, vol.65
, pp. 27
-
-
Middela, S.1
Pearce, I.2
-
88
-
-
85027953639
-
Renal infarction secondary to ketamine abuse
-
Chen, JL, Cha, TL, Wu, ST, Tang, SH, Tsao, CW, Meng, E, Renal infarction secondary to ketamine abuse. Am J Emerg Med 31 (2013), 1153.e3–1153.e5.
-
(2013)
Am J Emerg Med
, vol.31
, pp. 1153.e3-1153.e5
-
-
Chen, J.L.1
Cha, T.L.2
Wu, S.T.3
Tang, S.H.4
Tsao, C.W.5
Meng, E.6
-
89
-
-
44649184847
-
A pediatric case of ketamine-associated cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 2007; 69: 810–12)
-
Gregoire, MC, MacLellan, DL, Finley, GA, A pediatric case of ketamine-associated cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 2007; 69: 810–12). Urology 71 (2008), 1232–1233.
-
(2008)
Urology
, vol.71
, pp. 1232-1233
-
-
Gregoire, M.C.1
MacLellan, D.L.2
Finley, G.A.3
-
90
-
-
71049185534
-
Can ketamine prescribed for pain cause damage to the urinary tract?
-
Storr, TM, Quibell, R, Can ketamine prescribed for pain cause damage to the urinary tract?. Palliat Med 23 (2009), 670–672.
-
(2009)
Palliat Med
, vol.23
, pp. 670-672
-
-
Storr, T.M.1
Quibell, R.2
-
91
-
-
77954660031
-
Wherefore ketamine?
-
Persson, J, Wherefore ketamine?. Curr Opin Anaesthesiol 23 (2010), 455–460.
-
(2010)
Curr Opin Anaesthesiol
, vol.23
, pp. 455-460
-
-
Persson, J.1
-
92
-
-
84870907061
-
The prevalence and natural history of urinary symptoms among recreational ketamine users
-
Winstock, AR, Mitcheson, L, Gillatt, DA, Cottrell, AM, The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 110 (2012), 1762–1766.
-
(2012)
BJU Int
, vol.110
, pp. 1762-1766
-
-
Winstock, A.R.1
Mitcheson, L.2
Gillatt, D.A.3
Cottrell, A.M.4
-
93
-
-
53849124821
-
The destruction of the lower urinary tract by ketamine abuse: a new syndrome?
-
Chu, PS, Ma, WK, Wong, SC, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome?. BJU Int 102 (2008), 1616–1622.
-
(2008)
BJU Int
, vol.102
, pp. 1616-1622
-
-
Chu, P.S.1
Ma, W.K.2
Wong, S.C.3
-
94
-
-
79957868300
-
Recreational ketamine: from pleasure to pain
-
Wood, D, Cottrell, A, Baker, SC, et al. Recreational ketamine: from pleasure to pain. BJU Int 107 (2011), 1881–1884.
-
(2011)
BJU Int
, vol.107
, pp. 1881-1884
-
-
Wood, D.1
Cottrell, A.2
Baker, S.C.3
-
95
-
-
84961219147
-
Ketamine-induced apoptosis in normal human urothelial cells
-
Baker, SC, Shabir, S, Georgopoulos, N, Southgate, J, Ketamine-induced apoptosis in normal human urothelial cells. Am J Pathol 186 (2016), 1267–1277.
-
(2016)
Am J Pathol
, vol.186
, pp. 1267-1277
-
-
Baker, S.C.1
Shabir, S.2
Georgopoulos, N.3
Southgate, J.4
-
96
-
-
80052920605
-
Urinary symptoms and impaired quality of life in female ketamine users: persistence after cessation of use
-
Cheung, RY, Chan, SS, Lee, JH, Pang, AW, Choy, KW, Chung, TK, Urinary symptoms and impaired quality of life in female ketamine users: persistence after cessation of use. Hong Kong Med J 17 (2011), 267–273.
-
(2011)
Hong Kong Med J
, vol.17
, pp. 267-273
-
-
Cheung, R.Y.1
Chan, S.S.2
Lee, J.H.3
Pang, A.W.4
Choy, K.W.5
Chung, T.K.6
-
97
-
-
80051801177
-
Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases
-
Noppers, IM, Niesters, M, Aarts, LP, et al. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases. Pain 152 (2011), 2173–2178.
-
(2011)
Pain
, vol.152
, pp. 2173-2178
-
-
Noppers, I.M.1
Niesters, M.2
Aarts, L.P.3
-
98
-
-
80052744525
-
The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use
-
Kalsi, SS, Wood, DM, Dargan, PI, The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J, 4, 2011, 7107.
-
(2011)
Emerg Health Threats J
, vol.4
, pp. 7107
-
-
Kalsi, S.S.1
Wood, D.M.2
Dargan, P.I.3
-
99
-
-
84863692226
-
Ketamine for chronic noncancer pain: concerns regarding toxicity
-
Bell, RF, Ketamine for chronic noncancer pain: concerns regarding toxicity. Curr Opin Support Palliat Care 6 (2012), 183–187.
-
(2012)
Curr Opin Support Palliat Care
, vol.6
, pp. 183-187
-
-
Bell, R.F.1
-
100
-
-
80051801062
-
Ketamine hepato-toxicity in chronic pain management: another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data?
-
Sear, JW, Ketamine hepato-toxicity in chronic pain management: another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data?. Pain 152 (2011), 1946–1947.
-
(2011)
Pain
, vol.152
, pp. 1946-1947
-
-
Sear, J.W.1
-
101
-
-
0026528194
-
Location of enkephalinase and functional effects of [Leu5]enkephalin and inhibition of enkephalinase in the feline main pancreatic and bile duct sphincters
-
Thune, A, Jivegard, L, Pollard, H, Moreau, J, Schwartz, JC, Svanvik, J, Location of enkephalinase and functional effects of [Leu5]enkephalin and inhibition of enkephalinase in the feline main pancreatic and bile duct sphincters. Clin Sci (Lond) 82 (1992), 169–173.
-
(1992)
Clin Sci (Lond)
, vol.82
, pp. 169-173
-
-
Thune, A.1
Jivegard, L.2
Pollard, H.3
Moreau, J.4
Schwartz, J.C.5
Svanvik, J.6
-
102
-
-
48549085136
-
Prospective evaluation of adjunctive ketamine on sphincter of Oddi motility in humans
-
Varadarajulu, S, Tamhane, A, Wilcox, CM, Prospective evaluation of adjunctive ketamine on sphincter of Oddi motility in humans. J Gastroenterol Hepatol 23 (2008), e405–e409.
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. e405-e409
-
-
Varadarajulu, S.1
Tamhane, A.2
Wilcox, C.M.3
-
103
-
-
79958281271
-
Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series
-
Lo, RS, Krishnamoorthy, R, Freeman, JG, Austin, AS, Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series. Singapore Med J 52 (2011), e52–e55.
-
(2011)
Singapore Med J
, vol.52
, pp. e52-e55
-
-
Lo, R.S.1
Krishnamoorthy, R.2
Freeman, J.G.3
Austin, A.S.4
-
104
-
-
32144440105
-
Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users
-
Morgan, CJ, Rossell, SL, Pepper, F, et al. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biol Psychiatry 59 (2006), 265–272.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 265-272
-
-
Morgan, C.J.1
Rossell, S.L.2
Pepper, F.3
-
105
-
-
0029095652
-
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers
-
Hartvig, P, Valtysson, J, Lindner, KJ, et al. Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clin Pharmacol Ther 58 (1995), 165–173.
-
(1995)
Clin Pharmacol Ther
, vol.58
, pp. 165-173
-
-
Hartvig, P.1
Valtysson, J.2
Lindner, K.J.3
-
106
-
-
0028323167
-
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
-
Krystal, JH, Karper, LP, Seibyl, JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994), 199–214.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 199-214
-
-
Krystal, J.H.1
Karper, L.P.2
Seibyl, J.P.3
-
107
-
-
0029927565
-
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers
-
Malhotra, AK, Pinals, DA, Weingartner, H, et al. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14 (1996), 301–307.
-
(1996)
Neuropsychopharmacology
, vol.14
, pp. 301-307
-
-
Malhotra, A.K.1
Pinals, D.A.2
Weingartner, H.3
-
108
-
-
28444468469
-
Altered prefrontal dopaminergic function in chronic recreational ketamine users
-
Narendran, R, Frankle, WG, Keefe, R, et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 162 (2005), 2352–2359.
-
(2005)
Am J Psychiatry
, vol.162
, pp. 2352-2359
-
-
Narendran, R.1
Frankle, W.G.2
Keefe, R.3
-
109
-
-
34548294171
-
The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome
-
Koffler, SP, Hampstead, BM, Irani, F, et al. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol 22 (2007), 719–729.
-
(2007)
Arch Clin Neuropsychol
, vol.22
, pp. 719-729
-
-
Koffler, S.P.1
Hampstead, B.M.2
Irani, F.3
-
110
-
-
0004975091
-
WHO model prescribing information: drugs used in anaesthesia
-
(accessed Feb 1, 2017).
-
WHO. WHO model prescribing information: drugs used in anaesthesia. http://apps.who.int/medicinedocs/en/d/Jh2929e/4.html, 1989 (accessed Feb 1, 2017).
-
(1989)
-
-
-
111
-
-
84893124516
-
Ketamine for chronic pain: Risks and benefits
-
Niesters, M, Martini, C, Dahan, A, Ketamine for chronic pain: Risks and benefits. Br J Clin Pharmacol 77 (2014), 357–367.
-
(2014)
Br J Clin Pharmacol
, vol.77
, pp. 357-367
-
-
Niesters, M.1
Martini, C.2
Dahan, A.3
-
112
-
-
58749114718
-
Ketamine for chronic non-cancer pain
-
Bell, R, Ketamine for chronic non-cancer pain. Pain 141 (2009), 210–214.
-
(2009)
Pain
, vol.141
, pp. 210-214
-
-
Bell, R.1
-
113
-
-
85040146616
-
Anaesthetic apocalypse. Ketamine part 2: addictive psychedelic
-
Jansen, K, Anaesthetic apocalypse. Ketamine part 2: addictive psychedelic. Druglink(March/April), 2000, 18–21.
-
(2000)
Druglink
, Issue.March/April
, pp. 18-21
-
-
Jansen, K.1
-
114
-
-
0026496669
-
Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists
-
Lu, Y, France, CP, Woods, JH, Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists. J Pharmacol Exp Ther 263 (1992), 499–504.
-
(1992)
J Pharmacol Exp Ther
, vol.263
, pp. 499-504
-
-
Lu, Y.1
France, C.P.2
Woods, J.H.3
-
115
-
-
0017743081
-
Ketamine self-administration by the rhesus monkey
-
Moreton, JE, Meisch, RA, Stark, L, Thompson, T, Ketamine self-administration by the rhesus monkey. J Pharmacol Exp Ther 203 (1977), 303–309.
-
(1977)
J Pharmacol Exp Ther
, vol.203
, pp. 303-309
-
-
Moreton, J.E.1
Meisch, R.A.2
Stark, L.3
Thompson, T.4
-
116
-
-
77950473226
-
A case of ketamine dependence
-
(in Polish).
-
Blachut, M, Solowiow, K, Janus, A, et al. A case of ketamine dependence. Psychiatr Pol 43 (2009), 593–609 (in Polish).
-
(2009)
Psychiatr Pol
, vol.43
, pp. 593-609
-
-
Blachut, M.1
Solowiow, K.2
Janus, A.3
-
117
-
-
0036756573
-
Ketamine as a preferred substance of abuse
-
Bobo, WV, Miller, SC, Ketamine as a preferred substance of abuse. Am J Addict 11 (2002), 332–334.
-
(2002)
Am J Addict
, vol.11
, pp. 332-334
-
-
Bobo, W.V.1
Miller, S.C.2
-
118
-
-
33745771302
-
A case of ketamine dependence with discontinuation symptoms
-
Critchlow, DG, A case of ketamine dependence with discontinuation symptoms. Addiction 101 (2006), 1212–1213.
-
(2006)
Addiction
, vol.101
, pp. 1212-1213
-
-
Critchlow, D.G.1
-
119
-
-
0023406003
-
A case of ketamine dependence
-
(in Polish).
-
Florkowski, A, Ferfecki, L, A case of ketamine dependence. Psychiatr Pol 21 (1987), 434–435 (in Polish).
-
(1987)
Psychiatr Pol
, vol.21
, pp. 434-435
-
-
Florkowski, A.1
Ferfecki, L.2
-
120
-
-
0037256772
-
Ketamine associated psychedelic effects and dependence
-
Lim, DK, Ketamine associated psychedelic effects and dependence. Singapore Med J 44 (2003), 31–34.
-
(2003)
Singapore Med J
, vol.44
, pp. 31-34
-
-
Lim, D.K.1
-
121
-
-
0035986149
-
Ketamine dependence
-
Pal, HR, Berry, N, Kumar, R, Ray, R, Ketamine dependence. Anaesth Intensive Care 30 (2002), 382–384.
-
(2002)
Anaesth Intensive Care
, vol.30
, pp. 382-384
-
-
Pal, H.R.1
Berry, N.2
Kumar, R.3
Ray, R.4
-
122
-
-
84944351815
-
Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine's antidepressant response and the development of ketamine addiction
-
Bonnet, U, Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine's antidepressant response and the development of ketamine addiction. J Psychoactive Drugs 47 (2015), 276–285.
-
(2015)
J Psychoactive Drugs
, vol.47
, pp. 276-285
-
-
Bonnet, U.1
-
123
-
-
4844229862
-
Assessing harmful effects in systematic reviews
-
McIntosh, HM, Woolacott, NF, Bagnall, AM, Assessing harmful effects in systematic reviews. BMC Med Res Methodol, 4, 2004, 19.
-
(2004)
BMC Med Res Methodol
, vol.4
, pp. 19
-
-
McIntosh, H.M.1
Woolacott, N.F.2
Bagnall, A.M.3
-
124
-
-
0035828451
-
Assessment of therapeutic safety in systematic reviews: literature review
-
Ernst, E, Pittler, MH, Assessment of therapeutic safety in systematic reviews: literature review. BMJ, 323, 2001, 546.
-
(2001)
BMJ
, vol.323
, pp. 546
-
-
Ernst, E.1
Pittler, M.H.2
-
125
-
-
20544439606
-
Challenges in systematic reviews that assess treatment harms
-
Chou, R, Helfand, M, Challenges in systematic reviews that assess treatment harms. Ann Intern Med 142 (2005), 1090–1099.
-
(2005)
Ann Intern Med
, vol.142
, pp. 1090-1099
-
-
Chou, R.1
Helfand, M.2
-
126
-
-
84872792216
-
Some improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011
-
Golder, S, Loke, YK, Zorzela, L, Some improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011. J Clin Epidemiol 66 (2013), 253–260.
-
(2013)
J Clin Epidemiol
, vol.66
, pp. 253-260
-
-
Golder, S.1
Loke, Y.K.2
Zorzela, L.3
-
127
-
-
0020372215
-
Difficulties in assessing adverse drug reactions in clinical trials
-
Naranjo, C, Busto, U, Sellers, E, Difficulties in assessing adverse drug reactions in clinical trials. Prog Neuropsychopharmacol Biol Psychiatry 6 (1982), 651–657.
-
(1982)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.6
, pp. 651-657
-
-
Naranjo, C.1
Busto, U.2
Sellers, E.3
|